Related Experiment Video
Updated: Jan 30, 2026

Transient Middle Cerebral Artery Occlusion Model of Neonatal Stroke in P10 Rats
Published on: April 21, 2017
Transient Improvement of Cerebellar Oligodendroglial Development in a Neonatal Hyperoxia Model by PDGFA Treatment
Till Scheuer1, Luisa Sophie Klein1, Christoph Bührer1
1Department for Neonatology, Charité University Medical Center, Berlin, Germany.
Insights
High oxygen exposure in preterm infants damages cerebellar white matter. Platelet-derived growth factor-A (PDGFA) transiently improved oligodendrocyte proliferation and myelination in a rat model, but benefits were not long-lasting.
Area of Science:
- Neuroscience
- Developmental Biology
- Neonatal Research
Background:
- Preterm birth can lead to cerebellar white matter damage due to altered oxygen levels.
- Hyperoxia exposure in neonatal rats mimics increased arterial oxygen tension, impacting cerebellar development.
- Growth factor (GF) synthesis in cerebellar astrocytes and oligodendrocyte progenitor cell (OPC) function are critical for white matter development.
Purpose of the Study:
- To investigate the effects of hyperoxia on GF synthesis in cerebellar astrocytes.
- To analyze OPC function following hyperoxia exposure.
- To evaluate the therapeutic potential of PDGFA in protecting oligodendroglia and promoting myelination in a neonatal hyperoxia model.
Main Methods:
- Hyperoxia exposure (80% O2 for 24h) in a rat model from postnatal day 6 (P6) to P7.
- Magnetic-activated cell sorting (MACS) isolation of cerebellar astrocytes and OPCs for ex vivo and in vitro analysis.
- Assessment of GF expression (Pdgfa, Fgf2, Bdnf) in astrocytes and gene expression (Olig1, Olig2, Sox9, Sox10, Cnp) in OPCs.
- Nasal administration of PDGFA from P6 to P11 to assess its protective effects on oligodendroglia and myelination (MBP expression).
Main Results:
- Hyperoxia significantly reduced the expression of Pdgfa, Fgf2, and Bdnf in cerebellar astrocytes.
- Gene expression of key oligodendrocyte markers (Olig1, Olig2, Sox9, Sox10, Cnp) was decreased in OPCs following hyperoxia.
- Nasal PDGFA administration transiently improved oligodendroglial proliferation and attenuated impaired myelin basic protein (MBP) expression, but these effects diminished after treatment cessation.
Conclusions:
- Neonatal cerebellar injury due to hyperoxia impairs astrocyte growth factor synthesis and oligodendrocyte development.
- PDGFA treatment shows promise for improving oligodendroglial proliferation and myelination in the short term.
- The therapeutic benefits of PDGFA are not sustained long-term, highlighting the need for further research into sustained treatment strategies for neonatal cerebellar white matter injury.
Abstract:
In preterm infants, the changes from fetal life to ex-utero conditions often coincide with reduced growth and white matter damage of the cerebellum. The premature increase in arterial oxygen tension caused by preterm birth may dysregulate cerebellar development. In a hyperoxia rat model of white matter damage to mimic a steep increase in oxygen levels by 24 h exposure to 80% O2 from postnatal day 6 (P6) to day 7, we analyzed growth factor (GF) synthesis of cerebellar astrocytes. Determination of GF production was performed in astrocytes after Magnetic-activated cell sorting (MACS) isolation from cerebelli after hyperoxia exposure ex vivo, and also in astroglial cultures. Oligodendrocyte progenitor cell (OPC) function was analyzed in cerebellar OPCs isolated by MACS after hyperoxia. Administration of PDGFA from P6 to P11, during hyperoxia and during 4 days recovery, was finally tested for protection of oligodendroglia and myelination. As a result, expression of the GFs Pdgfa, Fgf2, and Bdnf was diminished in cerebellar astrocytes in vitro and in vivo. Gene expression of Olig1, Olig2, Sox9, Sox10, and Cnp was reduced in OPCs in vivo. Nasal PDGFA application improved oligodendroglial proliferation after hyperoxia at P7. However, this treatment effect vanished until P9. Impaired MBP expression after hyperoxia was attenuated by PDGFA treatment until P11, but not beyond when PDGFA supply was stopped. In this study on neonatal cerebellar injury, it is documented for the first time that improvement of oligodendroglial proliferation and of myelination can be achieved by PDGFA treatment. However, the treatment benefit is not maintained long term.
Related Concept Videos
Series R—L Circuit Transients
Using Kirchhoff's Voltage Law (KVL) to analyze this circuit helps determine the total asymmetrical fault current, which consists...
Sustainable Development
Transient and Steady-state Response
These test signals are integral in designing control systems to exhibit two key performance aspects: transient response and steady-state...
Improving Translational Accuracy
Improving Translational Accuracy
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

